Vulcan’s $1B Raise Comes at a 34% Discount
Vulcan (ASX: VUL) announced today that it has completed its institutional placement at an offer price of A$4 per share. This represents a steep 34% discount to the last traded price of A$6.31 and a 21 percent discount to the theoretical ex-rights price of A$5.06. The institutional…
Step One Falls Flat
Step One (ASX: STP) experienced a heavy re-rating today, falling 35% in a single session. That is a substantial hit for any investor owning shares. The catalyst was the release of its H126 trading update, and the numbers came in well below expectations. Revenue is now forecast to land between A$30…
Argenica’s ARG-007 Clears the Way
Argenica Therapeutics (ASX: AGN) surged 22% today after confirming that its tenecteplase drug interaction study for ARG 007 met a key FDA requirement needed to lift the clinical hold on its US Investigational New Drug application. The study showed that ARG 007 does not interfere with the clot-dissolving activity of…
Woodside Energy (ASX: WDS) is the ASX's largest energy company, capped at nearly $50bn. A traditional oil and gas giant, a large player in the LNG, many would perceive it is part of the problem that increased carbon emissions represent and that the planet would be better off without it. Whether or not that is…
Let's take a look at Australia's Future Fund. Specifically how it grew to A$260bn in Funds Under Management (FUM) (not even counting for other funds the parent company operates other than its namesake flagship fund) and what it is investing in now.
What are the Best ASX Stocks to invest in right now?
Check our buy/sell…
Saluda Medical (ASX:SLD) listed on Friday after raising AU$230 million at AU$2.65 per share, marking a rare bright spot in an otherwise quiet year for ASX biotech debuts. Unlike most life sciences IPOs that arrive with little more than clinical-stage promise, Saluda Medical already generates US$70 million in annual revenue and is targeting US$82 million…
Optiscan Imaging (ASX: OIL) has partnered with Australian Clinical Labs to launch Australia's first-in-human head and neck cancer imaging study. The ground-breaking study will recruit 50 patients at the St John of God Healthcare campus in Murdoch and will be led by prominent Perth head and neck cancer surgeon Dr Chady Sader. For investors tracking…
Australian GDP in Q3 shows that its economy is...complicated. Growth is stronger than last year, but the latest quarterly numbers fell short of expectations. Australia’s GDP rose by 0.4% in the September quarter, missing market expectations of 0.7%, according to data released by the Australian Bureau of Statistics. While annual GDP accelerated to 2.1%, the…
Vulcan Energy Resources (ASX: VUL) has secured a landmark €2.2 billion (A$3.9 billion) financing package to fully fund Phase One of its Lionheart lithium and renewable energy project in Germany. The announcement triggered a trading halt and enabled the board to make a Final Investment Decision, with construction scheduled to begin this Friday. This marks…
Perseus Mining (ASX: PRU) has stunned the market with a bold A$2.1 billion offer to buy Predictive Discovery (ASX: PDI), cutting in on the explorer’s planned deal with Canada’s Robex Resources. The all-share bid values Predictive at A$0.778 per share, representing a strong premium over recent prices, and has already secured the backing of Predictive’s…
